Based on these results we next attempted at examining a molecular function of APRIL and TWEAK in pancreatic cancer as well as the role of intratumoral TWEAK and APRIL expression as a predictor for patients survival. The gene discussed is TNFSF13; the disease is pancreatic neoplasm.